HHS invests nearly $600 million in Moderna’s bird flu vaccine development
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
US awards Moderna $590 million for bird flu vaccine development
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, alongside other influenza vaccines, health officials announced Friday.
Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
Moderna gets $590M HHS contract to develop mRNA pandemic flu vaccines
Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.
Moderna Gets $590 Million from US to Study Bird Flu Vaccine
Moderna Inc. was awarded an additional $590 million from the US government to help the company develop a vaccine aimed at protecting people from bird flu.Most Read from BloombergThese Homes Withstood the LA Fires.
Moderna confirms $590M award by U.S. for bird flu vaccine development
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of
Moderna: Can They Benefit From Bird Flu? (Rating Upgrade)
Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads significantly. Read my MRNA analysis.
S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential
The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest rate outlook.
Moderna awarded $590M by U.S. for bird flu vaccine development, Reuters reports
The U.S. Department of Health and Human Services has awarded Moderna (MRNA) $590M to “advance the late-stage development of its mRNA bird flu
The Edge Singapore11h
Moderna gets US$590 mil from US to study bird flu vaccine
The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been ...
Moderna Gets $590 Million in Federal Funding for Bird Flu Vaccine
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
As avian influenza A(H5N1) concerns continue, mRNA vaccines offer great potential
With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...